ROCK inhibition activates MCF-7 CellsIntroduction

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Yang, Seungwon ^a   Kim, Hyun Man ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CELL MARKER; RAC1 PROTEIN; RHO KINASE; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL ACTIVATION; CELL DISRUPTION; CELL JUNCTION; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL TRANSFER; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PROTEIN DEPLETION; TUMOR INVASION; UPREGULATION;

BETA CATENIN; CADHERINS; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; MICROSCOPY, CONFOCAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RAC1 GTP-BINDING PROTEIN; RHO-ASSOCIATED KINASES; RNA, SMALL INTERFERING;

EID: 84895732357     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088489     Document Type: Article

References (54)

1. Trimboli AJ, Fukino K, de Bruin A, Wei G, Shen L, et al. (2008) Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res 68: 937-945. (Pubitemid 351206773)
2. Dave B, Mittal V, Tan NM, Chang JC (2012) Epithelial-mesenchymal transition, cancer stem cells and treatment resistance. Breast Cancer Res 14: 202.
3. Aguirre-Ghiso JA (2007) Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 7: 834-846.
4. Paez D, Labonte MJ, Bohanes P, Zhang W, Benhanim L, et al. (2012) Cancer Dormancy: A Model of Early Dissemination and Late Cancer Recurrence. Clin Cancer Res 18: 645-653.
5. Brackstone M, Townson JL, Chambers AF (2007) Tumour dormancy in breast cancer: an update. Breast Cancer Res 9: 208.
6. Willis L, Alarcon T, Elia G, Jones JL, Wright NA, et al. (2010) Breast Cancer Dormancy Can Be Maintained by Small Numbers of Micrometastases. Cancer Res 70: 4310-4317.
7. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, et al. (1996) Phosphorylation and activation of myosin by Rho-associated kinase (Rhokinase). J Biol Chem 271: 20246-20249. (Pubitemid 26281788)
8. Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, et al. (1999) Signaling from rho to the actin cytoskeleton through protein kinases ROCK and LIMkinase. Science 285: 895-898. (Pubitemid 29381991)
9. Tian YS, Kim HJ, Kim HM (2009) Rho-associated kinase (ROCK) inhibition reverses low cell activity on hydrophobic surfaces. Biochem Biophys Res Commun 386: 499-503.
10. Yang S, Tian YS, Lee YJ, Yu FH, Kim HM (2011) Mechanisms by which the inhibition of specific intracellular signaling pathways increase osteo blast proliferation on apatite surfaces. Biomaterials 32: 2851-2861.
11. Yang S, Kim HM (2012) The RhoA-ROCK-PTEN pathway as a molecular switch for anchorage dependent cell behavior. Biomaterials 33: 2902-2915.
12. Zheng L, Kim HM (2012) Low-Rac1 activity downregulates MC3T3-E1 osteoblastic cell motility on a nanoscale topography prepared on polystyrene substrates in vitro. J Biomed Mater Res A 101: 1629-1636.
13. Barkan D, Green JE, Chambers AF (2010) Extracellular matrix: A gatekeeper in the transition from dormancy to metastatic growth. Eur J Cancer 46: 1181-1188.
14. Satoh K, Fukumoto Y, Shimokawa H (2011) Rho-kinase: important new therapeutic target in cardiovascular diseases. Am J Physiol-Heart C 301: H287-H296.
15. Shimokawa H, Takeshita A (2005) Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscl Throm Vas 25: 1767-1775. (Pubitemid 41243442)
16. Loirand G, Pacaud P (2010) The role of rho protein signaling in hypertension. Nat Rev Cardiol 7: 637-647.
17. Fujita H, Fukumoto Y, Saji K, Sugimura K, Demachi J, et al. (2010) Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension. Heart Vessels 25: 144-149.
18. Lee GY, Kenny PA, Lee EH, Bissell MJ (2007) Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods 4: 359-365. (Pubitemid 46766981)
19. Barkan D, Kleinman H, Simmons JL, Asmussen H, Kamaraju AK, et al. (2008) Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res 68: 6241-6250.
20. Tomschy A, Fauser C, Landwehr R, Engel J (1996) Homophilic adhesion of E-cadherin occurs by a co-operative two-step interaction of N-terminal domains. Embo J 15: 3507-3514. (Pubitemid 26239762)
21. Gottardi CJ, Gumbiner BM (2001) Adhesion signaling: How beta-catenin interacts with its partners. Curr Biol 11: R792-R794. (Pubitemid 32931007)
22. Akhtar N, Hudson KR, Hotchin NA (2000) Co-localization of Rac1 and E-cadherin in human epidermal keratinocytes. Cell Adhes Commun 7: 465-476.
23. Hu LM, Hittelman W, Lu T, Ji P, Arlinghaus R, et al. (2009) NGAL decreases E-cadherin-mediated cell-cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells. Lab Invest 89: 531-548.
24. Ray RM, Vaidya RJ, Johnson LR (2007) MEK/ERK regulates adherens junctions and migration through Rac1. Cell Motil Cytoskel 64: 143-156.
25. Braga VMM, Betson M, Li XD, Lamarche-Vane N (2000) Activation of the small GTPase Rac is sufficient to disrupt cadherin-dependent cell-cell adhesion in normal human keratinocytes. Mol Biol Cell 11: 3703-3721.
26. Lozano E, Frasa MAM, Smolarczyk K, Knaus UG, Braga VMM (2008) PAK is required for the disruption of E-cadherin adhesion by the small GTPase Rac. J Cell Sci 121: 933-938. (Pubitemid 351639412)
27. Hage B, Meinel K, Baum I, Giehl K, Menke A (2009) Rac1 activation inhibits E-cadherin-mediated adherens junctions via binding to IQGAP1 in pancreatic carcinoma cells. Cell Commun Signal 7: 23.
28. Yamaguchi Y, Katoh H, Yasui H, Mori K, Negishi M (2001) RhoA inhibits the nerve growth factor-induced Rac1 activation through Rho-associated kinase-dependent pathway. J Biol Chem 276: 18977-18983.
29. Guilluy C, Garcia-Mata R, Burridge K (2011) Rho protein crosstalk: another social network? Trends Cell Biol 21: 718-726.
30. Yang WH, Lan HY, Huang CH, Tai SK, Tzeng CH, et al. (2012) RAC1 activation mediates Twist1-induced cancer cell migration. Nat Cell Biol 14: 366-374.
31. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, et al. (1993) Occludin - a Novel Integral Membrane-Protein Localizing at Tight Junctions. J Cell Biol 123: 1777-1788. (Pubitemid 24012933)
32. Larue L, Bellacosa A (2005) Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3 ' kinase/AKT pathways. Oncogene 24: 7443-7454. (Pubitemid 41637984)
33. Toker A, Yoeli-Lerner M (2006) Akt signaling and cancer: Surviving but not moving on. Cancer Res 66: 3963-3966.
34. Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, van Roy F, et al. (2003) The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 63: 2172-2178. (Pubitemid 36538623)
35. Zavadil J, Bottinger EP (2005) TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24: 5764-5774.
36. Peng J, Zhang G, Wang QS, Huang JG, Ma H, et al. (2012) ROCK Cooperated with ET-1 to Induce Epithelial to Mesenchymal Transition through SLUG in Human Ovarian Cancer Cells. Biosci Biotech Bioch 76: 42-47.
37. Croft DR, Sahai E, Mavria G, Li SX, Tsai J, et al. (2004) Conditional ROCK activation in vivo induces tumor cell dissemination and angiogenesis. Cancer Res 64: 8994-9001. (Pubitemid 39665509)
38. Thiery JP (2003) Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15: 740-746.
39. Samarin SN, Ivanov AI, Flatau G, Parkos CA, Nusrat A (2007) Rho/Rho-associated kinase-II signaling mediates disassembly of epithelial apical junctions. Mol Biol Cell 18: 3429-3439. (Pubitemid 47378682)
40. Bolos V, Peinado H, Perez-Moreno MA, Fraga MF, Esteller M, et al. (2003) The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 116: 499-511. (Pubitemid 36231290)
41. Come C, Magnino F, Bibeau F, Barbara PD, Becker KF, et al. (2006) Snail and slug play distinct roles during breast carcinoma progression. Clin Cancer Res 12: 5395-5402. (Pubitemid 44497253)
42. Tsuji T, Ishizaki T, Okamoto M, Higashida C, Kimura K, et al. (2002) ROCK and mDia1 antagonize in Rho-dependent Rac activation in Swiss 3T3 fibroblasts. J Cell Biol 157: 819-830. (Pubitemid 34847819)
43. Ohta Y, Hartwig JH, Stossel TP (2006) FilGAP, a Rho- and ROCK-regulated GAP for Rac binds filamin A to control actin remodelling. Nat Cell Biol 8: 803-814. (Pubitemid 44151583)
44. Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, et al. (2008) Rac Activation and Inactivation Control Plasticity of Tumor Cell Movement. Cell 135: 510-523.
45. Brown JH, Del Re DP, Sussman MA (2006) The Rac and Rho hall of fame - A decade of hypertrophic signaling hits. Circ Res 98: 730-742.
46. Schuldt A (2011) Cell Growth Rac1 Sizes up Mtor. Nat Rev Mol Cell Bio 12: 343-343.
47. Waterman-Storer CM, Worthylake RA, Liu BP, Burridge K, Salmon ED (1999) Microtubule growth activates Rac1 to promote lamellipodial profusion in fibroblasts. Nat Cell Biol 1: 45-50. (Pubitemid 129495009)
48. Stam JC, Michiels F, van der Kammen RA, Moolenaar WH, Collard JG (1998) Invasion of T-lymphoma cells: cooperation between Rho family GTPases and lysophospholipid receptor signaling. Embo J 17: 4066-4074. (Pubitemid 28333990)
49. Xue B, Krishnamurthy K, Allred DC, Muthuswamy SK (2013) Loss of Par3 promotes breast cancer metastasis by cornpromising cell-cell cohesion. Nat Cell Biol 15: 189-200.
50. Monaghan-Benson E, Burridge K (2013) Mutant B-RAF regulates a Rac-dependent cadherin switch in melanoma. Oncogene 32: 4836-4844.
51. Yan D, Avtanski D, Saxena NK, Sharma D (2012) Leptin-induced Epithelial-Mesenchymal Transition in Breast Cancer Cells Requires beta-Catenin Activation via Akt/GSK3- and MTA1/Wnt1 Protein-dependent Pathways. J Biol Chem 287: 8598-8612.
52. Li JL, Zhou BHP (2011) Activation of beta-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters. Bmc Cancer 11: 49.
53. Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D, et al. (2006) Tumor invasion in the absence of epithelial-mesenchymal transition: Podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 9: 261-272.
54. Salhia B, Rutten F, Nakada M, Beaudry C, Berens M, et al. (2005) Inhibition of Rho-kinase affects astrocytoma morphology, motility, and invasion through activation of Rac1. Cancer Res 65: 8792-8800. (Pubitemid 41377367)